For those that have not been keeping up with the Theranos saga, here is a summary. Prior to the last year, a diagnostics company based in Northern California quietly grew to a value of nine billion dollars on one major premise: they could perform most common blood tests with a fraction of the blood of usual tests, and therefore could obtain this blood much more simply than a traditional drawing of a blood sample. Because of simpler collection, volumes, and...
Items tagged diagnostic testing
Get the latest content from Everly.